Apoorva Mandavilli © 2021 The New York Times Company

Opinions/Stories

Will ‘forever boosting’ beat the coronavirus?

Now, faced with the extraordinarily contagious omicron variant, Israel has begun offering fourth doses to some high-risk groups.

via The New York Times
Read Article

Will the vaccines stop Omicron? Scientists are racing to find out.

Scientists have reacted more quickly to omicron than to any other variant. In just 36 hours from the first signs of trouble in South Africa on Tuesday, researchers analyzed samples from 100…

via The New York Times
Read Article

Moderna’s COVID vaccine produces strong immune response in younger children

One month after immunisation was complete, the children in Moderna’s trial had antibody levels that were 1.5 times higher than those seen in young adults, the company said

via The New York Times
Read Article

Is the coronavirus getting better at airborne transmission?

People infected with the alpha variant had copious amounts of virus in their nose and throat, much more than those infected with the original virus.

via The New York Times
Read Article

The delta variant is the symptom of a bigger threat: Vaccine refusal

The more contagious delta variant may be getting the blame, but fueling its rise is an older, more familiar foe: vaccine hesitancy and refusal, long pervasive in the United States

via The New York Times
Read Article

Reaching ‘herd immunity’ is unlikely in the US, experts now believe

Continued immunizations, especially for people at highest risk because of age, exposure or health status, will be crucial to limiting the severity of outbreaks, if not their frequency, experts…

via The New York Times
Read Article

Can vaccinated people spread the virus? We don’t know, scientists say

The assertion called into question the precautions that the agency had urged vaccinated people to take just last month, like wearing masks and gathering only under limited circumstances with…

via The New York Times
Read Article